PALB2 mutation as a predictive biomarker for immunotherapy in patients with advanced melanoma: Results from (a pooled analysis of) five multicenter, randomized clinical trials. The PPV thresholds can ...
Preferences for research participation among individuals with Lynch syndrome: Findings from the HEROIC Registry. Real-world evidence of treatment patterns and pharmacy costs among patients with ...
Data is almost always incomplete. Patients drop out of clinical trials and survey respondents skip questions; schools fail to report scores, and governments ignore elements of their economies. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback